{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:22:33Z","timestamp":1765545753645,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,3]],"date-time":"2013-10-03T00:00:00Z","timestamp":1380758400000},"content-version":"vor","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30900451","81071045"],"award-info":[{"award-number":["30900451","81071045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["10151018201000021"],"award-info":[{"award-number":["10151018201000021"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013286","name":"Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20104423110003"],"award-info":[{"award-number":["20104423110003"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.seizure.2012.06.014","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T20:45:14Z","timestamp":1342817114000},"page":"614-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: Incidence, features, risk factors and relation to HLA-B alleles"],"prefix":"10.1016","volume":"21","author":[{"given":"Na","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Li","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Mei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Xiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2012.06.014_bib0005","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/13543784.8.7.1103","article-title":"Oxcarbazepine: current status and clinical applications","volume":"8","author":"Schachter","year":"1999","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.seizure.2012.06.014_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1345\/aph.10417","article-title":"Newer therapies in the drug treatment of epilepsy","volume":"36","author":"McAuley","year":"2002","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.seizure.2012.06.014_bib0015","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0149-2918(01)80019-9","article-title":"Oxcarbazepine, an antiepileptic agent","volume":"23","author":"Kalis","year":"2001","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.seizure.2012.06.014_bib0020","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2012.06.014_bib0025","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Rash from antiepileptic drugs: influence by gender, age, and learning disability","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.06.014_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2012.01.019","article-title":"Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy","author":"Wang","year":"2012","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.seizure.2012.06.014_bib0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1607-551X(09)70045-2","article-title":"Oxcarbazepine-induced Stevens\u2013Johnson syndrome: a case report","volume":"25","author":"Lin","year":"2009","journal-title":"Kaohsiung Journal of Medical Sciences"},{"key":"10.1016\/j.seizure.2012.06.014_bib0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","article-title":"Common risk allele in aromatic antiepileptic-drug induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in Han Chinese","volume":"11","author":"Hung","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.seizure.2012.06.014_bib0045","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.arcped.2004.05.018","article-title":"Oxcarbazepine and DRESS syndrome: a paediatric cause of acute liver failure","volume":"11","author":"Bosdure","year":"2004","journal-title":"Archives de Pediatrie"},{"key":"10.1016\/j.seizure.2012.06.014_bib0050","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15563650802342104","article-title":"Oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"46","author":"D\u2019Orazio","year":"2008","journal-title":"Clinical Toxicology (Philadelphia)"},{"key":"10.1016\/j.seizure.2012.06.014_bib0055","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.lpm.2010.04.014","article-title":"Oxcarbazepine drug rash with eosinophilia and systemic symptoms (DRESS) syndrome mimicking septic shock","volume":"39","author":"Chakarian","year":"2010","journal-title":"Presse Medicale"},{"key":"10.1016\/j.seizure.2012.06.014_bib0060","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1528-1167.2007.01041.x","article-title":"Idiosyncratic adverse reactions to antiepileptic drugs","volume":"48","author":"Zaccara","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.06.014_bib0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.seizure.2010.11.014","article-title":"Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population","volume":"20","author":"Hu","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2012.06.014_bib0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.seizure.2012.06.014_bib0075","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.seizure.2012.06.014_bib0080","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1399-0039.2007.00932.x","article-title":"HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1 DPB1) alleles and haplotypes in the Han from southern China","volume":"70","author":"Trachtenberg","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.seizure.2012.06.014_bib0085","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/j.seizure.2012.06.014_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1742-7843.2011.00681.x","article-title":"HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population","volume":"109","author":"Shi","year":"2011","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"10.1016\/j.seizure.2012.06.014_bib0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2307\/2531055","article-title":"On the bias of commonly used measures of association for 2\u00d72 tables","volume":"42","author":"Jewell","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.seizure.2012.06.014_bib0100","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1528-1167.2009.02489.x","article-title":"Safety profile of oxcarbazepine: results from a prescription-event monitoring study","volume":"51","author":"Buggy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.06.014_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Safety"},{"key":"10.1016\/j.seizure.2012.06.014_bib0110","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.54.12.2245","article-title":"Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial","volume":"54","author":"Beydoun","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2012.06.014_bib0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.06.014_bib0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1525-5050(02)00028-8","article-title":"Concomitant use of divalproex sodium and lamotrigine in developmentally disabled patients with epilepsy: a retrospective evaluation of efficacy and tolerability","volume":"3","author":"Maganti","year":"2002","journal-title":"Epilepsy and Behavior"},{"key":"10.1016\/j.seizure.2012.06.014_bib0125","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1345\/aph.18422","article-title":"Factors influencing the incidence of lamotrigine-related skin rash","volume":"33","author":"Wong","year":"1999","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/j.seizure.2012.06.014_bib0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0920-1211(99)00039-X","article-title":"Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy The UK Lamotrigine Elderly Study group","volume":"37","author":"Brodie","year":"1999","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2012.06.014_bib0135","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"68","author":"Arif","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2012.06.014_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.eplepsyres.2008.04.003","article-title":"Cross-reactivity pattern of rash from current aromatic antiepileptic drugs","volume":"80","author":"Alvestad","year":"2008","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2012.06.014_bib0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.seizure.2010.09.003","article-title":"Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population","volume":"19","author":"Wang","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2012.06.014_bib0150","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.seizure.2012.06.014_bib0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.seizure.2012.06.014_bib0160","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.seizure.2011.02.003","article-title":"Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland","volume":"20","author":"Wang","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2012.06.014_bib0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","article-title":"Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China","volume":"19","author":"Wu","year":"2010","journal-title":"Epilepsy and Behavior"},{"key":"10.1016\/j.seizure.2012.06.014_bib0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eplepsyres.2010.10.006","article-title":"Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B*1502 in a Han Chinese population","volume":"92","author":"An","year":"2010","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.seizure.2012.06.014_bib0175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2012.06.014_bib0180","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/FPC.0b013e32832c347d","article-title":"High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients","volume":"19","author":"Kazeem","year":"2009","journal-title":"Pharmacogenet Genomics"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131112001744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131112001744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:41:52Z","timestamp":1761010912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131112001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1059131112001744"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2012.06.014","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: Incidence, features, risk factors and relation to HLA-B alleles","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2012.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}